| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.44 | 0.01 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.48 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |